Questions to ask your doctor about HRT: the complete prepared-patient guide

First, a five-minute history lesson that explains everything

If you've absorbed a vague sense that hormone therapy is dangerous, it has one main source: the Women's Health Initiative (WHI), a large trial whose 2002 results made global headlines and cut HRT use by more than half almost overnight. What the headlines skipped: the average participant was 63 years old — more than a decade past menopause — and many were studied on one specific formulation (oral conjugated estrogens with a synthetic progestin). The scary-sounding relative risks, translated to absolute numbers, were on the order of a handful of additional events per 10,000 women per year.

Two decades of re-analysis and newer research produced a more precise picture, now reflected in The Menopause Society's position statements: for symptomatic women who start hormone therapy before age 60 or within 10 years of their final period, the benefits generally outweigh the risks. Age at initiation, time since menopause, dose, route (patch vs pill), and your personal history all move the calculus. That's the "timing window" your clinician should discuss — and if they instead recite a blanket "hormones cause cancer, no," they're practicing 2002 medicine.

Hold onto one skill from this section: always ask for risks in absolute numbers. "Doubles the risk" can mean 1-in-10,000 becoming 2-in-10,000. Relative risk frightens; absolute risk informs.

Know the menu before you order

"HRT" is not one thing. A quick map of what's actually on the table:

• Systemic estrogen — reaches the whole body; treats hot flashes, night sweats, and sleep disruption. Comes as a patch, gel, or spray (absorbed through skin) or a pill. The route matters: transdermal estrogen bypasses the liver and is associated with lower blood-clot risk than oral — often preferred for women with any clot-risk factors.
• A progestogen — required alongside systemic estrogen if you have a uterus, because unopposed estrogen overstimulates the uterine lining. Options include micronized progesterone (body-identical, taken at night, mildly sedating — often a feature, not a bug) and synthetic progestins. A hormonal IUD can serve this role in some regimens.
• Low-dose vaginal estrogen — cream, tablet, or ring acting locally on vaginal and urinary tissue, with minimal absorption into the bloodstream. Treats dryness, painful sex, and recurrent UTIs. Because it's local, its risk profile is very different from systemic therapy — many women who can't or don't want systemic HRT can still use it.
• Combination products — patches and pills that package estrogen and progestogen together.

On "bioidentical": the word just means structurally identical to your own hormones — and many FDA-approved products already are (estradiol patches, micronized progesterone). What the major societies caution against is custom-compounded hormones from compounding pharmacies: they aren't held to the same standards for dose consistency, purity, and labeling, and marketing claims that they're "safer" or "natural" have no evidence behind them. If someone is selling you compounded pellets plus a panel of saliva tests, that's a red flag, not a premium service.

The questions, grouped for the appointment

Round 1 — Am I a candidate?

1. Based on my symptoms and history, am I a good candidate for hormone therapy — and if not, what specifically rules it out?
2. I'm [X] years old and roughly [X] years from my last period. Does the timing window favor starting now rather than waiting?
3. Which of my symptoms would HRT most likely improve — and which would it probably not touch? (Good answer: flashes, night sweats, and sleep respond best; some benefits for mood in perimenopause; it is *not* a cure-all for weight or every ache.)
4. What results should I expect in the first 3 months, and how will we measure success?
5. Given my personal history [clots / migraine with aura / family breast cancer / high blood pressure — name yours], how does that change my options? (Good answer engages specifics — e.g., migraine with aura or clot history often steers toward transdermal routes — rather than a flat yes/no.)

Round 2 — Which formulation, exactly?

1. Would you recommend systemic therapy or local vaginal estrogen for my symptom mix — or both?
2. If systemic: patch or pill, and why for someone with my risk profile? (Listen for: transdermal bypasses the liver, lower clot risk.)
3. I have a uterus — which progestogen, on what schedule, and why that one? (Micromized progesterone vs synthetic progestins vs hormonal IUD is a real choice with real differences.)
4. Are we starting at the lowest effective dose, and what's the plan for adjusting?
5. Is this product FDA-approved? If you're suggesting compounded hormones, what's the specific reason an approved product won't work for me?

Round 3 — Risks, honestly

1. What are my risks on this regimen — breast cancer, clots, stroke — in absolute numbers, not relative ones?
2. Which warning signs mean I should stop and call you immediately? (Good answer includes: signs of a clot — one-sided leg swelling, sudden shortness of breath, chest pain — plus any new unexplained vaginal bleeding.)
3. How does my regimen affect mammograms or screening — anything to time differently?
4. How often will we re-evaluate whether continuing still makes sense — annually? (There's no automatic stop-date anymore, but there should be a standing review.)

Round 4 — Alternatives and add-ons

1. If I can't or don't want to take hormones, what are the best non-hormonal options for my main symptom? (For flashes: certain SSRIs/SNRIs — low-dose paroxetine is FDA-approved — plus gabapentin, oxybutynin, and fezolinetant, a newer drug targeting the brain pathway behind flashes. CBT and clinical hypnosis have real evidence for reducing how disruptive flashes feel.)
2. For vaginal dryness or painful sex specifically: what about low-dose vaginal estrogen, moisturizers, and lubricants — and do I need the systemic version at all if this is my only symptom? (Usually: no.)
3. For sleep, is treating the night sweats likely to fix it, or should we also consider CBT-I?
4. If we do nothing for now, what does watchful waiting look like — and what developments would change your recommendation?
5. What's the plan for my bones and heart either way? (Estrogen loss accelerates bone loss; this deserves a plan regardless of your HRT decision.)

Round 5 — Practicalities

1. What does this cost with my insurance, and is there a generic version? (Generic estradiol patches and micronized progesterone exist and are often inexpensive.)
2. Who do I contact with problems between visits, and how fast can we adjust if side effects show up?
3. What side effects are normal in the first weeks (breast tenderness, spotting, bloating are common early and often settle) versus ones that mean we should change course?

Special situations worth naming explicitly

• History of breast cancer — systemic HRT is generally contraindicated; symptom management shifts to the non-hormonal menu, and even local vaginal estrogen requires an individualized oncology conversation. You deserve a clinician fluent in this specific situation.
• Migraine with aura — often steers toward transdermal estrogen at steady doses rather than oral; say the word 'aura' out loud so it enters the calculus.
• History of blood clots or clotting disorders — not always an absolute bar anymore, but it demands the transdermal-route conversation and sometimes a hematology opinion.
• Early menopause or POI (before 40–45) — a different framework entirely: hormone treatment until the natural age of menopause is generally *recommended* to protect bones and heart, not merely permitted.
• Hysterectomy (uterus removed) — you likely need estrogen only, no progestogen, which simplifies the regimen and the risk math.
• Years past menopause (60+ or 10+ years out) — starting *new* systemic HRT here has a different risk profile; expect (and deserve) a more cautious conversation. Local vaginal estrogen remains an option at any age.

Red flags — in the room, in either direction

Be wary of the two opposite failure modes. The reflexive no: "hormones are dangerous, absolutely not" with zero discussion of your age, timing, or profile — that's the 2002 headline talking, not current guidance. The reflexive yes: hormones pitched as a fountain of youth fixing everything from wrinkles to weight, usually alongside expensive compounded pellets, saliva-test panels, and no risk conversation whatsoever — that's a sales funnel wearing a stethoscope. A good clinician personalizes, quantifies, offers alternatives, and schedules follow-up.

If you hit either wall, a second opinion is reasonable and normal. The Menopause Society maintains a directory of certified menopause practitioners on menopause.org — clinicians who have specifically trained and tested in this care. Telehealth menopause clinics have also made specialist access dramatically easier; just apply the same red-flag filters to them (the good ones prescribe FDA-approved products and discuss risk like adults).

Before you go: the one-page prep

• Top three symptoms, ranked by life disruption — sleep, work, relationships. Lead with #1.
• Cycle status — date of last period, how cycles have changed. (Tracking guide: early signs of perimenopause.)
• Personal history — clots, migraine with aura, blood pressure, liver disease, any unexplained bleeding.
• Family history — breast cancer, ovarian cancer, heart disease, clots — with ages if you know them.
• Current medications and supplements — all of them, including the "natural" ones.
• Your starting position — "I'm leaning toward trying it," "I want alternatives first," or "I just want to understand my options." Saying it out loud focuses the whole appointment.